期刊文献+

血管内皮生长因子受体1在血液系统肿瘤中的研究进展 被引量:1

Research advancement of vascular endothelial growth factor receptor 1 in hematological malignancies
下载PDF
导出
摘要 新生血管形成在血液系统肿瘤的发生、发展和预后中起重要作用,血管内皮生长因子(VEGF)作为血管生成调控因子,起着关键作用。已经证实VEGF及其受体在多种肿瘤包括血液系统肿瘤中高表达并与疾病的分期、预后相关,针对VEGF及其受体为靶点的抗血管治疗也取得初步的成功。 Angiogenesis plays a very important role in the growth, progression and prognosis of hematological malignancies. Vascular endothelial growth factor(VEGF) is a potent angiogenic factor in regulating angiogenesis. It has been reported that the patients of hematological malignancies overexpress VEGF and its receptors correlated with poor prognosis. VEGF and its receptors have been shown to be a target for treating tumors.
出处 《国际内科学杂志》 CAS 2007年第4期239-242,共4页 International Journal of Internal Medicine
关键词 血管内皮生长因子 受体 血液肿瘤 Vascular endothelial growth factor Receptor Hematological malignancies
  • 相关文献

参考文献19

  • 1Bellamy WT.Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies.Semin Oncol,2001,28(6):551-559.
  • 2Kharfan-Dabaja MA,Patel SA,Osunkoya AO,et al.Expression of the vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukemia:incidence and feasibility of immunohistochemical staining.Clin Lab Haematol,2006,28 (4):254-258.
  • 3Aref S,E1 Sherbiny M,Goda T,et al.Soluble VEGF/sFltl ratio is an independent predictor of AML patient outcome.Hematology,2005,10 (2):131-134.
  • 4Aguayo A,Kantarjian HM,Estey EH,et al.Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.Cancer,2002,95(9):1923 -1930.
  • 5Niitsu N,Okamato M,Nakamine H,et al.Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma.Eur J Haematol,2002,68 (2):91-100.
  • 6Hazar B,Paydas S,Zorludemir S,et al.Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma.Leuk Lymphoma,2003,44(12):2089-2093.
  • 7Giles FJ,Vose JM,Do KA,et al.Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma.Leuk Res,2004,28 (6):595-604.
  • 8Ho CL,Sheu LF,Li CY,et al.Immunohistochemical expression of angiogenic cytokines and their receptors in reac tive benign lymph nodes and non-Hodgkin lymphoma.Ann Diagn Pathol,2003,7 (1):1-8.
  • 9Kumar S,Witzig TE,Timm M,et al.Expression of VEGF and its receptors by myeloma cells.Leukemia,2003,17 (10):2025-2031.
  • 10Usnarska-Zubkiewicz L,Mazur G,Wrobel T,et al.Expression of serum vascular endothelial growth factor correlates with clinical outcome in multiple myeloma.Pol Arch Med Wewn,2003,110(1):719-724.

同被引文献21

  • 1季冬梅,洪小南.抗肿瘤新生血管治疗的新进展[J].肿瘤,2006,26(12):1127-1130. 被引量:5
  • 2Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis [ J ]. J Biochem Mol Biol, 2006,39(5 ) :469-478.
  • 3Fong GH, Rossant J, Gertsentein M,et al. Role of the Fit-1 receptor tyrosine kinase in regulation the assembly of vascular endothelial [ J]. Nature, 1995,376 ( 6535 ) :66-70.
  • 4Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice [ J]. Nature, 1995,376 ( 6535 ) :62-66.
  • 5Dixelius J, Makinen T, Wirzenius M,et al. Ligand-indueed vascular endothelial growth factor receptor-3 ( VEGFR-3 ) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites [ J ]. J Biol Chem, 2003,278 ( 42 ) : 40973 -40979.
  • 6Alam A, lterault JP, Barron P, et al. Heterodimerization with vascular endothelial growth factor receptor-2 (VEGFR-2) is necessary for VEGFR-3 activity [ J ]. Biochem Biophys Res Commun,2004, 324(2) :909-915.
  • 7Saito M, Hamasaki M, Shibuya M. Induction of tube formation by angiopoietin endothelial cell/fibroblast co-cuhure is dependent on endogenous VEGF [ J ]. Cancer Sci, 2003,94 ( 9 ) : 782-790.
  • 8Yoshiji H, Kuriyama S, Noguehi R,et al. Angiopoietin-2 displays a vascular endothelial growth factor dependent synergistic effect in heputocellular carcinoma development in mice [ J ]. Gut, 2005,54(12):1768-1775.
  • 9Cheng N,Brantley DM, Chen J. The ephrins and Eph receptorss in angiogenesis[J]. Cytokine Growth Factor Rev, 2002, 13 (1): 75 -85.
  • 10Zhang J,Hughes SE. Role of tile ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system [ J ]. J Pathol, 2006,208 ( 4 ) : 453-461.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部